Skip to content
Filings

Concentrix Corporation CNXC Form 8-K filing Earnings

Filed
Jun 29, 2026, 4:02 PM EDT
Accession
0001803599-26-000133

Exhibit 99.1

Concentrix Reports Second Quarter 2026 Results

  • Revenue and profit within guidance as reported
  • A record-high second quarter $258M in cash flow from operations, $242M in adjusted free cash flow
  • iX Suite deals up 400% year over year

Newark, Calif., June 29, 2026 – Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced financial results for the fiscal second quarter ended May 31, 2026.

Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025Change
Revenue ($M)$2,462.5$2,417.41.9%
Operating income ($M)$95.4$148.3(35.7)%
Non-GAAP operating income ($M) (1)$292.0$303.7(3.9)%
Operating margin3.9%6.1%-220 bps
Non-GAAP operating margin (1)11.9%12.6%-70 bps
Net income ($M)$55.3$42.131.4%
Non-GAAP net income ($M) (1)$168.6$179.6(6.1)%
Adjusted EBITDA ($M) (1)$347.4$357.3(2.8)%
Adjusted EBITDA margin (1)14.1%14.8%-70 bps
Diluted earnings per common share$0.86$0.6336.5%
Non-GAAP diluted earnings per common share (1)$2.63$2.70(2.6)%

(1) See non-GAAP reconciliations included in the accompanying financial tables for the reconciliation of each non-GAAP measure to its most directly comparable GAAP measure.

Second Quarter Fiscal 2026 Highlights:

  • Revenue of $2,462.5 million, an increase of 1.9% year-on-year on an as reported basis compared to revenue of $2,417.4 million in the prior year second quarter. The Company grew revenue 0.6% year-on-year on a constant currency basis.
  • Operating income of $95.4 million, or 3.9% of revenue, compared to $148.3 million, or 6.1% of revenue, in the prior year second quarter.
  • Non-GAAP operating income of $292.0 million, or 11.9% of revenue, compared with $303.7 million, or 12.6% of revenue in the prior year second quarter.
  • Adjusted EBITDA of $347.4 million, or 14.1% of revenue, compared with $357.3 million, or 14.8% of revenue in the prior year second quarter.
  • Cash flow provided by operations was $257.9 million in the quarter. Adjusted free cash flow(1) was $242.3 million in the quarter.
  • Diluted earnings per common share (“EPS”) was $0.86 compared to $0.63 in the prior year second quarter.
  • Non-GAAP diluted EPS was $2.63 compared to $2.70 in the prior year second quarter.

“Our second quarter marked an acceleration in many areas in the evolution of our business,” said Chris Caldwell, President and CEO of Concentrix. “Our blended AI and services approach is delivering value to clients by lowering their costs and increasing their revenue, helping us differentiate ourselves in the marketplace."

Quarterly Dividend and Share Repurchase Program:

  • The Company paid a $0.36 per share quarterly dividend on May 5, 2026. The Company’s Board of Directors has declared a quarterly dividend of $0.36 per share payable on August 4, 2026, to shareholders of record at the close of business on July 24, 2026.
  • The Company did not repurchase any shares under its share repurchase program during the second quarter of fiscal year 2026. At May 31, 2026, the Company’s remaining share repurchase authorization was $396.6 million.

Business Outlook:

The following statements are based on the Company’s current expectations for the third quarter and the full year fiscal 2026. Non-GAAP financial measures exclude the impact of acquisition-related, integration and restructuring expenses, amortization of intangible assets, depreciation, loss on held for sale, share-based compensation and the related tax effects thereon. The non-GAAP EPS guidance assumes no impact from changes in acquisition contingent consideration and foreign currency losses (gains), net included in other expense (income), net. These statements are forward-looking and actual results may differ materially.

Third Quarter Fiscal 2026 Expectations:

  • Third quarter reported revenue of $2.465 billion to $2.490 billion. Based on current exchange rates, these expectations assume an approximate 75-basis point negative impact of foreign exchange rates compared with the prior year period. The guidance implies constant currency revenue growth for the quarter ranging from 0.0% to 1.0%.
  • Operating income of $121 million to $131 million and non-GAAP operating income of $295 million to $305 million.
  • Non-GAAP diluted EPS of $2.65 to $2.77, assuming approximately 60.9 million diluted common shares outstanding and approximately 4.8% of net income attributable to participating securities.
  • The effective tax rate is expected to be approximately 25%.

Full Year 2026 Expectations:

  • Full year reported revenue of $9.925 billion to $10.025 billion. Based on current exchange rates, these expectations assume an approximate 75-basis point positive impact of foreign exchange rates compared with the prior year. The guidance implies constant currency revenue growth for the full year of 0.25% to 1.25%.
  • Operating income of $509 million to $539 million and non-GAAP operating income of $1,200 million to $1,230 million.
  • Non-GAAP diluted EPS of $10.83 to $11.18, assuming approximately 61.1 million diluted common shares outstanding and approximately 4.8% of net income attributable to participating securities.
  • The effective tax rate is expected to be approximately 24.5%.

In addition, the Company expects to generate approximately $630.0 million to $650.0 million of adjusted free cash flow in fiscal year 2026.

The Company believes that a quantitative reconciliation of the non-GAAP EPS outlook to the most directly comparable GAAP measure cannot be provided without unreasonable efforts due to (a) the inability to forecast future changes in acquisition contingent consideration, which is based, in part, on the future trading price of the Company’s common stock, and (b) the inability to forecast future foreign currency losses (gains), net included in other expense (income), net. For the same reason, the Company is unable to address the probable significance of the unavailable information, which may have a material impact on the Company’s GAAP results.

The Company believes that a quantitative reconciliation of the adjusted free cash flow outlook to the most directly comparable GAAP measure cannot be provided without unreasonable efforts due to uncertainty related to the future changes in the Company’s factoring program and related timing of those changes. For the same reason, the Company is unable to address the probable significance of the unavailable information, which may have a material impact on the Company’s GAAP results.

Conference Call and Webcast

The Company will host a conference call for investors to review its second quarter fiscal 2026 results today at 5:00 p.m. (ET)/2:00 p.m. (PT).

The live conference call webcast will be available in listen-only mode in the Investor Relations section of the Company’s website under “Events and Presentations” at https://ir.concentrix.com/events-and-presentations. A replay will also be available on the website following the conference call.

About Concentrix: Powering a World That Works

Concentrix Corporation (NASDAQ: CNXC), is the Fortune 500® technology and services company, helping the world's best brands create intelligent operations that perform in the real world. We design, build, and run integrated human and AI solutions, harnessing the insight from billions of real-world interactions to help 2,000+ of the world’s most complex organizations solve their toughest business challenges. Backed by 20+ years of operational experience and battle tested AI, we’re the intelligent transformation partner that helps clients across every major industry move from ambition to measurable, scalable performance. Virtually everywhere. To learn more, visit concentrix.com.

Use of Non-GAAP Information

In addition to disclosing financial results that are determined in accordance with GAAP, we also disclose certain non-GAAP financial information, including:

  • Constant currency revenue growth, which is revenue growth adjusted for the translation effect of foreign currencies so that certain financial results can be viewed without the impact of fluctuations in foreign currency exchange rates, thereby facilitating period-to-period comparisons of our business performance. Constant currency revenue growth is calculated by translating the revenue of each fiscal year in the billing currency to U.S. dollars using the comparable prior year’s currency conversion rate in comparison to prior year’s revenue. Generally, when the U.S. dollar either strengthens or weakens against other currencies, revenue growth at constant currency rates or adjusting for currency will be higher or lower than revenue growth reported at actual exchange rates.
  • Non-GAAP operating income, which is operating income, adjusted to exclude acquisition-related, integration and restructuring expenses, step-up depreciation, amortization of intangible assets, loss on held for sale and share-based compensation.
  • Non-GAAP operating margin, which is non-GAAP operating income, as defined above, divided by revenue.
  • Adjusted earnings before interest, taxes, depreciation, and amortization, or adjusted EBITDA, which is non-GAAP operating income, as defined above, plus depreciation (exclusive of step-up depreciation).
  • Adjusted EBITDA margin, which is adjusted EBITDA, as defined above, divided by revenue.
  • Non-GAAP net income, which is net income excluding the tax-effected impact of acquisition-related, integration and restructuring expenses, step-up depreciation, amortization of intangible assets, loss on held for sale, share-based compensation, certain debt costs, imputed interest related to the Sellers’ Note, certain legal settlement costs, change in acquisition contingent consideration and foreign currency losses (gains), net. Non-GAAP net income also excludes the income tax effect of certain tax law changes.
  • Free cash flow, which is cash flows from operating activities less capital expenditures, and adjusted free cash flow, which is free cash flow excluding the effect of changes in the outstanding factoring balance. We believe that free cash flow is a meaningful measure of cash flows since capital expenditures are a necessary component of ongoing operations. We believe that adjusted free cash flow is a meaningful measure of cash flows because it removes the effect of factoring which changes the timing of the receipt of cash for certain receivables. However, free cash flow and adjusted free cash flow have limitations because they do not represent the residual cash flow available for discretionary expenditures. For example, free cash flow and adjusted free cash flow do not incorporate payments for business acquisitions.
  • Non-GAAP diluted EPS, which is diluted EPS excluding the per share, tax-effected impact of acquisition-related, integration and restructuring expenses, step-up depreciation, amortization of intangible assets, loss on held for sale, share-based compensation, certain debt costs, imputed interest related to the Sellers’ Note, certain legal settlement costs, change in acquisition contingent consideration and foreign currency losses (gains), net. Non-GAAP EPS also excludes the per share income tax effect of certain tax law changes. Non-GAAP EPS also reflects a per share adjustment to exclude non-GAAP net income attributable to participating securities.

We believe that providing this additional information is useful to the reader to better assess and understand our base operating performance, especially when comparing results with previous periods and for planning and forecasting in future periods, primarily because management typically monitors the business adjusted for these items in addition to GAAP results. Management also uses these non-GAAP measures to establish operational goals and, in some cases, for measuring performance for compensation purposes. These non-GAAP financial measures exclude amortization of intangible assets. Although intangible assets contribute to our revenue generation, the amortization of intangible assets does not directly relate to the services performed for our clients. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of our acquisition activity. Accordingly, we believe excluding the amortization of intangible assets, along with the other non-GAAP adjustments, which neither relate to the ordinary course of our business nor reflect our underlying business performance, enhances our and our investors’ ability to compare our past financial performance with our current performance and to analyze underlying business performance and trends. These non-GAAP financial measures also exclude share-based compensation expense. Given the subjective assumptions and the variety of award types that companies can use when calculating share-based compensation expense, management believes this additional information allows investors to make additional comparisons between our operating results and those of our peers. As these non-GAAP financial measures are not calculated in accordance with GAAP, they may not necessarily be comparable to similarly titled measures employed by other companies. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures and should be used as a complement to, and in conjunction with, data presented in accordance with GAAP.

CONSOLIDATED BALANCE SHEETS (currency and share amounts in thousands, except par value)

View SEC source
Line itemMay 31, 2026November 30, 2025
(unaudited)
ASSETS
Current assets:
Cash and cash equivalents$255,566$327,347
Accounts receivable, net1,987,9781,999,021
Assets held for sale202,738
Other current assets593,611758,135
Total current assets3,039,8933,084,503
Property and equipment, net709,829735,550
Goodwill3,653,4903,671,746
Intangible assets, net1,749,9091,960,338
Deferred tax assets343,201317,453
Other assets1,016,525991,496
Total assets$10,512,847$10,761,086
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$198,108$244,771
Current portion of long-term debt650,00065,625
Accrued compensation and benefits658,057764,962
Other accrued liabilities815,876997,198
Income taxes payable85,078123,794
Liabilities held for sale172,259
Total current liabilities2,579,3782,196,350
Long-term debt, net3,934,8744,572,889
Other long-term liabilities1,011,706950,983
Deferred tax liabilities285,603296,519
Total liabilities7,811,5618,016,741
Stockholders’ equity:
Preferred stock, $0.0001 par value, 10,000 shares authorized and no shares issued and outstanding as of May 31, 2026 and November 30, 2025, respectively
Common stock, $0.0001 par value, 250,000 shares authorized; 70,591 and 70,316 shares issued as of May 31, 2026 and November 30, 2025, respectively, and 60,863 and 61,739 shares outstanding as of May 31, 2026 and November 30, 2025, respectively77
Additional paid-in capital3,838,0823,783,972
Treasury stock, 9,728 and 8,577 shares as of May 31, 2026 and November 30, 2025, respectively(657,340)(610,162)
Retained deficit(146,518)(177,010)
Accumulated other comprehensive loss(332,945)(252,462)
Total stockholders’ equity2,701,2862,744,345
Total liabilities and stockholders’ equity$10,512,847$10,761,086

CONSOLIDATED STATEMENTS OF OPERATIONS

currency and share amounts in thousands, except per share amounts · unaudited

View SEC source
Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025% ChangeSix Months EndedMay 31, 2026Six Months EndedMay 31, 2025% Change
Revenue
Technology and consumer electronics$624,244$662,719(6)%$1,259,333$1,320,411(5)%
Retail, travel and e-commerce640,795583,78210%1,290,1581,167,68010%
Communications and media392,255392,963786,271763,9633%
Banking, financial services and insurance432,388384,01513%853,993749,20814%
Healthcare151,869176,386(14)%330,699366,191(10)%
Other220,922217,5062%442,410422,1405%
Total revenue$2,462,473$2,417,3712%$4,962,864$4,789,5934%
Cost of revenue1,639,1241,569,2234%3,289,8583,085,5467%
Gross profit823,349848,148(3)%1,673,0061,704,047(2)%
Selling, general and administrative expenses727,928699,8034%1,459,0261,386,8355%
Operating income95,421148,345(36)%213,980317,212(33)%
Interest expense and finance charges, net68,07475,406(10)%143,391148,400(3)%
Other expense (income), net(42,128)21,218(299)%(27,617)16,299(269)%
Income before income taxes69,47551,72134%98,206152,513(36)%
Provision for income taxes14,1999,62847%21,34140,163(47)%
Net income$55,276$42,09331%$76,865$112,350(32)%
Earnings per common share:
Basic$0.86$0.63$1.20$1.68
Diluted$0.86$0.63$1.20$1.68
Weighted-average common shares outstanding:
Basic60,85063,35561,06263,693
Diluted60,86263,40661,07863,733

CONCENTRIX CORPORATION RECONCILIATION OF GAAP TO NON-GAAP MEASURES

currency and share amounts in thousands, except per share amounts · unaudited

View SEC source
Line itemThree Months EndedMay 31, 2026Six Months EndedMay 31, 2026
Revenue$2,462,473$4,962,864
Revenue growth, as reported under U.S. GAAP1.9%3.6%
Foreign exchange impact(1.3)%(2.3)%
Constant currency revenue growth0.6%1.3%
Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025Six Months EndedMay 31, 2026Six Months EndedMay 31, 2025
Operating income$95,421$148,345$213,980$317,212
Acquisition-related, integration and restructuring expenses (1)65,50516,808100,37434,832
Step-up depreciation2,7012,5365,4564,912
Amortization of intangibles102,057109,158205,513214,777
Loss on held for sale9636,892
Share-based compensation25,36726,86254,82253,462
Non-GAAP operating income$292,014$303,709$587,037$625,195
Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025Six Months EndedMay 31, 2026Six Months EndedMay 31, 2025
Net income$55,276$42,093$76,865$112,350
Interest expense and finance charges, net68,07475,406143,391148,400
Provision for income taxes14,1999,62821,34140,163
Other expense (income), net(42,128)21,218(27,617)16,299
Acquisition-related, integration and restructuring expenses (1)65,50516,808100,37434,832
Step-up depreciation2,7012,5365,4564,912
Amortization of intangibles102,057109,158205,513214,777
Loss on held for sale9636,892
Share-based compensation25,36726,86254,82253,462
Depreciation (exclusive of step-up depreciation)55,36153,615108,519106,336
Adjusted EBITDA$347,375$357,324$695,556$731,531
Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025Six Months EndedMay 31, 2026Six Months EndedMay 31, 2025
Operating margin3.9%6.1%4.3%6.6%
Non-GAAP operating margin11.9%12.6%11.8%13.1%
Adjusted EBITDA margin14.1%14.8%14.0%15.3%
Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025Six Months EndedMay 31, 2026Six Months EndedMay 31, 2025
Net income$55,276$42,093$76,865$112,350
Acquisition-related, integration and restructuring expenses (1)65,50516,808100,37434,832
Step-up depreciation2,7012,5365,4564,912
Debt costs (2)1,1026,2681,102
Imputed interest related to Sellers’ Note included in interest expense and finance charges, net4,5038,689
Legal settlement costs (3)2,0002,000
Change in acquisition contingent consideration included in other expense (income), net(529)8,691(945)6,667
Foreign currency losses (gains), net (4)(44,965)10,789(32,659)6,610
Amortization of intangibles102,057109,158205,513214,777
Loss on held for sale9636,892
Share-based compensation25,36726,86254,82253,462
Income taxes related to the above (5)(37,805)(44,931)(85,862)(81,923)
Income tax effect of change in tax law4,269
Non-GAAP net income$168,570$179,611$336,724$367,747
Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025Six Months EndedMay 31, 2026Six Months EndedMay 31, 2025
Net income$55,276$42,093$76,865$112,350
Less: net income allocated to participating securities (6)(2,745)(2,035)(3,869)(5,448)
Net income attributable to common stockholders$52,531$40,058$72,996$106,902
Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025Six Months EndedMay 31, 2026Six Months EndedMay 31, 2025
Non-GAAP net income$168,570$179,611$336,724$367,747
Less: Non-GAAP net income allocated to participating securities (7)(8,371)(8,685)(16,949)(17,831)
Non-GAAP income attributable to common stockholders$160,199$170,926$319,775$349,916
Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025Six Months EndedMay 31, 2026Six Months EndedMay 31, 2025
Diluted earnings per common share (“EPS”) (6)$0.86$0.63$1.20$1.68
Acquisition-related, integration and restructuring expenses1.080.271.640.55
Step-up depreciation0.040.040.090.08
Debt costs (2)0.020.100.02
Imputed interest related to Sellers’ Note included in interest expense and finance charges, net0.070.14
Legal settlement costs (3)0.030.03
Change in acquisition contingent consideration included in other expense (income), net(0.01)0.14(0.02)0.10
Foreign currency losses (gains), net (4)(0.74)0.17(0.53)0.10
Amortization of intangibles1.681.723.363.37
Loss on held for sale0.020.11
Share-based compensation0.420.420.900.84
Income taxes related to the above (5)(0.62)(0.71)(1.41)(1.29)
Income tax effect of change in tax law0.07
Adjustment for participating securities (7)(0.10)(0.10)(0.20)(0.20)
Non-GAAP Diluted EPS (7)$2.63$2.70$5.24$5.49
Weighted-average number of common shares - diluted60,86263,40661,07863,733
Line itemThree Months EndedMay 31, 2026Three Months EndedMay 31, 2025Six Months EndedMay 31, 2026Six Months EndedMay 31, 2025
Net cash provided by operating activities$257,891$236,536$174,671$237,944
Purchases of property and equipment(48,174)(55,792)(102,076)(106,410)
Free cash flow209,717180,74472,595131,534
Change in outstanding factoring balances32,60719,54225,11628,936
Adjusted free cash flow$242,324$200,286$97,711$160,470
Line itemForecast · Three Months Ending August 31, 2026LowForecast · Three Months Ending August 31, 2026HighForecast · Fiscal Year Ending November 30, 2026LowForecast · Fiscal Year Ending November 30, 2026High
Revenue$2,465,000$2,490,000$9,925,000$10,025,000
Revenue growth, as reported under U.S. GAAP(0.75)%0.25%1.00%2.00%
Foreign exchange impact0.75%0.75%(0.75)%(0.75)%
Constant currency revenue growth0.0%1.0%0.25%1.25%
Line itemForecast · Three Months Ending August 31, 2026LowForecast · Three Months Ending August 31, 2026HighForecast · Fiscal Year Ending November 30, 2026LowForecast · Fiscal Year Ending November 30, 2026High
Operating income$120,900$130,900$508,808$538,808
Amortization of intangibles102,500102,500395,000395,000
Share-based compensation23,80023,800105,000105,000
Acquisition-related, integration and restructuring expenses45,00045,000175,000175,000
Step-up depreciation2,8002,8009,3009,300
Loss on held for sale6,8926,892
Non-GAAP operating income$295,000$305,000$1,200,000$1,230,000

(1) For the three and six months ended May 31, 2026, acquisition-related, integration and restructuring expenses primarily included restructuring costs associated with our recent cost reduction initiatives, including severance and employee-related costs. Restructuring expenses also included costs associated with facilities consolidation, including lease terminations. For the three and six months ended May 31, 2025, acquisition-related, integration and restructuring costs primarily included integration costs associated with our combination with Webhelp and restructuring expenses. These costs primarily included severance and employee-related costs, costs associated with facilities consolidation, including lease terminations to integrate the businesses, and information technology system consolidation costs.

(2) For the six months ended May 31, 2026, debt costs included debt extinguishment costs associated with our early redemption of $600 million of our senior notes due in August 2026. For the three and six months ended May 31, 2025, debt costs included debt extinguishment costs associated with our restated credit agreement and our voluntary prepayment of a portion of our outstanding term loans.

(3) For the three and six months ended May 31, 2025, legal settlement costs consist of amounts incurred to settle certain litigation arising outside of the ordinary course of business.

(4) Foreign currency losses (gains), net are included in other expense (income), net and primarily consist of gains and losses recognized on the revaluation and settlement of foreign currency transactions and realized and unrealized gains and losses on derivative contracts that do not qualify for hedge accounting.

(5) The tax effect of taxable and deductible non-GAAP adjustments was calculated using the tax-deductible portion of the expenses and applying the entity-specific, statutory tax rates applicable to each item during the respective periods presented.

(6) Diluted EPS is calculated using the two-class method, which is an earnings allocation proportional to the respective ownership among holders of common stock and participating securities. Restricted stock awards and certain restricted stock units granted to employees are considered participating securities. For the purposes of calculating diluted EPS, net income attributable to participating securities was approximately 5.0% and 4.8% of net income, respectively, for the three months ended May 31, 2026 and 2025 and 5.0% and 4.8% of net income, respectively, for the six months ended May 31, 2026 and 2025.

(7) For the purposes of calculating non-GAAP net income attributable to common shareholders and non-GAAP diluted EPS, non-GAAP net income attributable to participating securities was approximately 5.0% and 4.8% of non-GAAP net income, respectively, for the three months ended May 31, 2026 and 2025, and 5.0% and 4.8% of non-GAAP net income, respectively, for the six months ended May 31, 2026 and 2025, and was excluded from non-GAAP net income attributable to common shareholders to calculate non-GAAP diluted EPS.